Various findings on CT can indicate how far a patient has progressed along disease timeline.
An axial CT image obtained without intravenous contrast in a 42‐year‐old male in the “late” time group (10 days from symptom onset to this CT) shows bilateral consolidative opacities, with a striking peripheral distribution in the right lower lobe (solid arrows), and with a rounded morphology in the left lower lobe (dashed arrow). Image Courtesy: Radioloy Online
How frequently certain findings show up on a CT scan of a person infected with the coronavirus disease 19 (COVID-19) is directly related to where they are on the disease timeline.
In a new study published in Radiology, investigators from Mount Sinai Health System determined that various CT findings were more common at certain points during disease progression.
“Recognizing imaging patterns based on infection time course is paramount for not only understanding the pathophysiology and natural history of infection, but also for helping to predict patient progression and potential complication development,” wrote lead study author Adam Bernheim, M.D., assistant professor of diagnostic, molecular, and interventional radiology at Icahn School of Medicine at Mount Sinai.
Even though real-time reverse transcriptase polymerase chain reaction (rRT-PCR) kits can be used to diagnose COVID-19, many centers don’t have access to enough kits, and they also carry a possibility of false negative results. Consequently, Chinese health officials have largely recommended relying on clinical and chest CT findings for diagnosis.
To identify common CT findings based upon the time between symptom onset and initial CT exam, the research team analyzed chest CTs from 121 patients (61 men and 60 women) who had been diagnosed with and exhibited symptoms of COVID-19 from four centers in China from Jan. 18, 2020, to Feb. 2, 2020.
For 94 participants, researchers knew the time between the initial emergence of symptoms and a chest CT – early (0-2 days), intermediate (3-5 days), and late (6-12 days). Among those who were imaged early, the team found ground-glass abnormalities, as well as “crazy paving” development. A lack of ancillary chest CT findings, including lymphadenopathy, pleural effusions, pulmonary nodules, and lung cavitation is also characteristic of early COVID-19 cases. Individuals further along in the disease course exhibited increasing consolidation.
Further research is required to evaluate CT scan findings in chronic patients, according to the authors. The analysis could determine if long-term complications emerge.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.
2 Commerce Drive
Cranbury, NJ 08512